Multivariate analysis of associations between prognostic parameters and outcome
| End point . | Parameter . | P . |
|---|---|---|
| Complete remission | ||
| Day 16 blasts | < .0001 | |
| Age | .0036 | |
| LDH | .0072 | |
| Overall survival | ||
| Unfavorable cytogenetics | < .0001 | |
| Day 16 blasts | < .0001 | |
| Age | < .0001 | |
| LDH | .0040 | |
| Event-free survival | ||
| Unfavorable cytogenetics | < .0001 | |
| LDH | < .0001 | |
| Day 16 blasts | < .0001 | |
| Age | .0061 | |
| Relapse-free survival | ||
| Unfavorable cytogenetics | < .0001 | |
| LDH | < .0001 | |
| Day 16 blasts | .0359 |
| End point . | Parameter . | P . |
|---|---|---|
| Complete remission | ||
| Day 16 blasts | < .0001 | |
| Age | .0036 | |
| LDH | .0072 | |
| Overall survival | ||
| Unfavorable cytogenetics | < .0001 | |
| Day 16 blasts | < .0001 | |
| Age | < .0001 | |
| LDH | .0040 | |
| Event-free survival | ||
| Unfavorable cytogenetics | < .0001 | |
| LDH | < .0001 | |
| Day 16 blasts | < .0001 | |
| Age | .0061 | |
| Relapse-free survival | ||
| Unfavorable cytogenetics | < .0001 | |
| LDH | < .0001 | |
| Day 16 blasts | .0359 |
Only independent parameters are shown; parameters are sorted in order of significance.